IMMUNE RESPONSE CORP·4

Aug 11, 12:54 PM ET

THEOFAN GEORGIA 4

4 · IMMUNE RESPONSE CORP · Filed Aug 11, 2004

Insider Transaction Report

Form 4
Period: 2004-08-11
THEOFAN GEORGIA
VP, Clinical Development
Transactions
  • Award

    Common Stock

    2004-08-11$0.70/sh+5,000$3,50010,475 total

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT